Priority Applications (1) Applications Claiming Priority (4) Related Parent Applications (1) Publications (2) Family ID=46969763 Family Applications (3) Family Applications Before (1) Family Applications After (1) Country Status (8) Cited By (1) Families Citing this family (14) Citations (5) Family Cites Families (1) 2012 2012-04-02 AU AU2012240424A patent/AU2012240424B2/en active Active 2012-04-02 US US14/009,459 patent/US9150613B2/en active Active 2012-04-02 CA CA2832113A patent/CA2832113C/en active Active 2012-04-02 CN CN201280026925.2A patent/CN103582490B/en active Active 2012-04-02 WO PCT/US2012/031815 patent/WO2012138599A2/en not_active Ceased 2012-04-02 JP JP2014503898A patent/JP6173298B2/en active Active 2012-04-02 EP EP12768043.7A patent/EP2709650B1/en active Active 2012-04-02 ES ES12768043.7T patent/ES2622385T3/en active Active 2013 2013-02-15 US US13/768,497 patent/US8598118B2/en active Active 2015 2015-08-07 US US14/821,184 patent/US20170049843A1/en not_active Abandoned
GHK-Cu suppresses inflammation, supports tissue regeneration, and modulates immune signaling. Pickart & Margolina, Oxidative Medicine and Cellular Longevity GHKCu and Its Role in Wound Healing 1
A peer-reviewed study in the Journal of Cosmetic Dermatology found GHK-Cu reduced wrinkle volume by 55.8% and outperformed Matrixyl 3000 by 31.6% in wrinkle volume reduction
If skin were a building, fibroblasts would be the crew that pours the foundation and patches the walls
Having an abnormally low number of thrombocytes is known as (Arnold 2012
The staff are all fully qualified and highly experienced beauty therapists
